Medical News

RSS

Elsevier offers Arabic bilingual medical texts to major universities in the Middle East

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today it has begun offering Arabic bilingual editions of leading Elsevier medical texts to major universities in the Middle East. The first order was recently received by Kalamoon University in Syria.

7 Mar 2011

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

7 Mar 2011

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

ZIOPHARM Oncology, Inc., an oncology small molecule and synthetic biology drug development company, and Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today that they have entered into a license and collaboration agreement to develop and commercialize ZIOPHARM's darinaparsin product and related organic arsenic molecules in specified Pan-Asian/Pacific territories.

7 Mar 2011

UN Women Executive Director marks International Women's Day with a message

A hundred years ago today, women across the world took an historic step on the long road to equality. The first ever International Women's Day was called to draw attention to the unacceptable and often dangerous working conditions that so many women faced worldwide.

7 Mar 2011

New research: Lung cancer rates have doubled for women over 60 since mid 1970s

Lung cancer rates have doubled for women over 60 since the mid 1970s according to new Cancer Research UK figures released today ahead of No Smoking Day this Wednesday.

7 Mar 2011

RadNet executes definitive agreement to acquire imaging centers in Maryland

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 201 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire five multi-modality imaging centers in Maryland from Diagnostic Health Corporation for an undisclosed combination of cash and the assumption of certain liabilities.

7 Mar 2011

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell microorganisms, announces preliminary results of MRSA testing at the University of Texas Health Science Center - Houston. Dr. Jonathan Faro, M.D., Ph.D. has found NanoLogix technology is able to deliver results for MRSA in 6 hours, as opposed to conventional culture-based testing wait times of 24 to 48 hours.

7 Mar 2011

Carnot LSI launches new website for industrial contacts

Developed by Floralis, the University Joseph Fourier's technology transfer, the new website www.carnot-lsi.com www.carnot-lsi.com is more detailed comprehensive, more user-friendly and most of all more accessible to its target audience of industrial contacts.

7 Mar 2011

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.

7 Mar 2011

Scientists develop unique device to measure short-lived radioactive thoron

"Many people are now saying: 'Is it really that easy? Then why didn't anyone think of it a long time ago?' But you have to have the right idea at the right time," says Annette Röttger, physicist at the Physikalisch-Technische Bundesanstalt, in a pleased way. Annette Röttger and her scientific team managed to do something that was previously thought to be impossible: they developed a primary standard for the measurement of short-lived radioactive thoron.

7 Mar 2011

Sectra receives strategic order from Trillium for MicroDose Mammography system

The women of Canada will soon benefit from low-dose mammography. Trillium Radiology Associates, which operates private diagnostic imaging facilities in Toronto and Mississauga, has invested in four digital mammography systems from the IT and medical technology company Sectra. The system was sold by Xtron Imaging Inc., Sectra's new distribution partner for Canada.

7 Mar 2011

AusBiotech, WMDO to offer online medtech courses

WMDO, the leading global provider of innovative online training for medical device professionals, and AusBiotech, Australia's leading biotechnology industry organization, announced today a strategic partnership that offers AusBiotech Members access to WMDO's professional online training.

7 Mar 2011

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics, said the company had been granted a US patent for Sym004 as well as other antibody compositions containing at least two distinct anti-EGFR antibodies having certain binding characteristics.

7 Mar 2011

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

7 Mar 2011

Duchenne Parent Project awards grant to AMT for DMD gene therapy

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the Duchenne Parent Project, based in the Netherlands, has awarded AMT a grant of EUR 145,000 to support the development of AMT-080, AMT's gene therapy for Duchenne Muscular Dystrophy.

7 Mar 2011

Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders

AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.

7 Mar 2011

Study uncovers 13 new genes that increase risk of heart attacks

The largest-ever study of its type into coronary heart disease, involving scientists from the University of Leicester, has uncovered 13 new genes that increase risk of heart attacks.

7 Mar 2011

New website to encourage healthy behavior changes in Oklahomans

In 2010, Strong & Healthy Oklahoma, a division of the Oklahoma State Department of Health, conducted a 12-question survey to capture current physical activity, nutrition, and tobacco programs/resources across the state.

7 Mar 2011

Poll explores link between Americans' use of communication technologies and sleep habits

The 2011 Sleep in America- poll released today by the National Sleep Foundation finds pervasive use of communications technology in the hour before bed. It also finds that a significant number of Americans aren't getting the sleep they say they need and are searching for ways to cope.

7 Mar 2011

Launch Excellence Services provides solutions to new pharma product market entry

The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.

7 Mar 2011